2018
DOI: 10.1002/pbc.27093
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic experience with hepatoblastoma associated with trisomy 18

Abstract: Trisomy 18 is often fatal, but patients with this disease can now have longer survival due to proactive treatment intervention. However, hepatoblastomas may develop in these patients. In this study, we report four cases of hepatoblastoma associated with trisomy 18. All of the patients had congenital heart disease and three had undergone intracardiac surgical repair. Tumor growth was relatively slow in all cases, and there were no problems with chemotherapy tolerability and surgical resection. Three of the pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 19 publications
0
15
0
1
Order By: Relevance
“…Including the current reports, 46 patients with trisomy 18 and HB have been reported in the literature, including 23 patients reported in the Japanese literature and summarized in English elsewhere (Supporting Information Table S1). These patients were predominantly female (M:F 1:7.8), in contrast to a male predominance for patients not selected for trisomy 18 (M:F 1.2:1) . This appears to be related to the female predominance of patients with trisomy 18 surviving past the neonatal period with the recent increases in life‐sustaining treatment approaches .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Including the current reports, 46 patients with trisomy 18 and HB have been reported in the literature, including 23 patients reported in the Japanese literature and summarized in English elsewhere (Supporting Information Table S1). These patients were predominantly female (M:F 1:7.8), in contrast to a male predominance for patients not selected for trisomy 18 (M:F 1.2:1) . This appears to be related to the female predominance of patients with trisomy 18 surviving past the neonatal period with the recent increases in life‐sustaining treatment approaches .…”
Section: Resultsmentioning
confidence: 99%
“…1,2 Survival in infants with trisomy 18 has also improved. 3 There is a well-recognized association between HB and trisomy 18, 4 and as a result, resection of HB in children with trisomy 18 needs to be considered. Repair of congenital heart defects early in life reduces in-hospital mortality in these infants, 5 but some of them have chronic issues with Abbreviations: AFP, alpha-fetoprotein; CVP, central venous pressure; HB, hepatoblastoma; IVC, inferior vena cava; VSD, ventricular septal defect pulmonary hypertension.…”
Section: Introductionmentioning
confidence: 99%
“…Treatment for hepatoblastoma and Wilms' tumor may include surgical resection with or without chemotherapy. Cancer treatment is possible and has been successful in some circumstances but must be balanced with the burden to the child (Inoue et al, 2018). Due to the impact of trisomy 13 and 18 on multiple organ systems, treatment options should be considered collaboratively with an interdisciplinary care team and family.…”
Section: Cancermentioning
confidence: 99%
“…Trisomy 18, regarded as a fatal disease, affects approximately 1 per 6,000 newborns (30). The correlation between trisomy 18 and hepatoblastoma has been reported in several previous studies (21,(31)(32)(33). Tomlinson et al raised an interesting point that the hepatoblastoma cases with trisomy 18 almost were females, and this situation was contrary to hepatoblastoma with higher prevalence in males (34).…”
Section: Genetic Syndromesmentioning
confidence: 93%